营养递送和新陈代谢再激活疗法用于黑色素瘤
Yang Chen1,2, Chaochao Wang1,2, Yelin Wu1
1Department of Medical Ultrasound, Shanghai Tenth People's Hospital, Tongji University Cancer Center, School of Life Sciences and Technology, Tongji University, Shanghai, P. R. China.
Nature nanotechnology
|June 11, 2024
概括
这项研究引入了一种基于营养的新策略,通过重新激活代谢途径来治疗黑色素瘤. 通过光热疗法,L-tyrosine-oleylamine纳米粒 (MTyr-OANPs) 有效地抑制了黑色素瘤细胞的增殖,并通过光热疗法消除了瘤.
科学领域:
- 在瘤学瘤学.
- 代谢工程是代谢工程.
- 纳米医学是一种纳米医学.
背景情况:
- 瘤细胞表现出改变的新陈代谢,以支持快速增殖.
- 虽然抑制过度活化的新陈代谢会抑制瘤的生长,但重新激活下调的新陈代谢途径的治疗潜力在很大程度上尚未被探索.
- 黑色素瘤是一种重要的皮肤癌,具有独特的代谢挑战.
研究的目的:
- 研究一种以营养素为基础的代谢活性化策略,以有效治疗黑色素瘤.
- 在黑色素瘤细胞中开发L-tyrosine-oleylamine纳米细胞 (MTyr-OANPs) 用于向的氨酸补充和黑色素生成再激活.
- 为了评估MTyr-OANPs与光热疗法相结合的治疗疗效.
主要方法:
- 构建L-氨酸-oleylamine纳米粒 (MTyr-OANPs) 以有针对性的提供L-氨酸.
- 使用MTyr-OANPs重新激活黑色素瘤细胞中的黑色素生成.
- 评估黑色素瘤细胞增殖和糖解抑制.
- 使用B16F10黑色素瘤携带的小鼠接受MTyr-OANPs和光热治疗的体内研究.
主要成果:
- MTyr-OANPs治疗重新激活了黑色素的产生,显著阻碍了黑色素瘤细胞的增殖.
- 黑色素瘤细胞增殖主要通过抑制糖解抑制.
- 通过黑色素生成的黑色素作为一种有效的光热剂.
- 在B16F10黑色素瘤携带的小鼠中,通过联合MTyr-OANPs和光热疗法实现了完全的瘤根除.
结论:
- 代谢的重新激活,特别是黑色素形成,为黑色素瘤提供了一个可行的治疗策略.
- 使用纳米细胞的向营养补充可以有效调节瘤细胞代谢.
- 代谢活性和光热治疗的结合为黑色素瘤治疗提供了一种强有力的方法.
- 这项研究强调了特定营养素作为癌症治疗代谢途径激活剂的潜力.
相关概念视频
Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
Electron Transport Chain: Complex I and II
13.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.0K


